Emocha partners with Belgian firm to develop mobile diagnostic device
Emocha Mobile Health, a Baltimore health technology startup, has been tapped by miDiagnostics, a Belgian medical device company, to help develop diagnostic devices that can relay test results to smartphones and tablets.
MiDiagnostics, a collaboration between the Johns Hopkins University and Belgian nanoelectronics research center imec, is developing diagnostic tests that can be embedded in silicon chips. Emocha will build the cloud technology platform that will allow the test data to be transferred digitally.
The chips eventually could be used to improve a wide range of diagnostic tests, such as the complete blood count test, a common blood test used to diagnose diseases and monitor medical conditions. The partnership is a significant step for Emocha, as the company looks to validate its health data analysis technology and expand its reach, said CEO Sebastian Seiguer.